Pfizer (PFE) stock in focus as company faces lawsuits over its alleged failure to warn about brain tumor risks linked to Depo ...

Currently, a multidistrict litigation against Pfizer (NYSE: PFE) is underway on behalf of women who claim to have developed meningiomas after receiving four or more consecutive injections of ...

Depo-Provera is a birth control shot that is injected every three months and features a type of progestin hormone called ...

Tevogen ('Tevogen Bio Holdings Inc.” or 'Company”) (Nasdaq: TVGN) today announced the signing of a letter of intent to lease a 17,428-square-foot facility in New Jersey. The facility, formerly ...

The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally intervened to place restrictions on COVID shots from vaccine makers Novavax and ...

A well-known injectable birth control method is under fire after multiple studies linked it to a specific kind of brain tumor, and now, lawsuits are piling up against the drugmaker. […] The post ...

A new study has linked a type of injectable birth control with meningioma. The manufacturer says the claims are “without ...

Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

A 30-page federal lawsuit has been filed in the U.S. District Court of the Eastern District of Texas against Eastman Chemical ...

In 2025, the Depo-Provera lawsuit is real and legitimate. Millions have used it — but the risk of brain tumors was only ...

This month in the Zantac litigation, the Delaware Supreme Court tossed all the plaintiffs’ experts in thousands of cases, ...